{"totalResults":4249,"results":[{"description":"Lymphoma is cancer that begins in cells of the lymph system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Hodgkin lymphoma can often be cured. The prognosis of NHL depends on the specific type. Start here to find information about lymphoma treatment, research, and statistics.","title":"Lymphoma\u2014Patient Version - National Cancer Institute","contentType":"cgvCancerTypeHome","url":"https://www.cancer.gov/types/lymphoma"},{"description":"Lymphoma refers to cancers that form in the lymphatic system, including Hodgkin lymphoma, non-Hodgkin lymphoma, AIDS-related lymphoma, and primary CNS lymphoma. Find evidence-based information on lymphoma treatment, research, genomics, and statistics.","title":"Lymphoma\u2014Health Professional Version - National Cancer Institute","contentType":"cgvCancerTypeHome","url":"https://www.cancer.gov/types/lymphoma/hp"},{"description":"An overview of recent research results and progress related to the treatment of Hodgkin lymphoma and non-Hodgkin lymphoma, including research on targeted therapies and immunotherapies. Selected NCI-supported programs that address lymphoma are also described.","title":"Advances in Lymphoma Research - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/types/lymphoma/research"},{"description":"Find research articles on lymphoma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.","title":"Lymphoma Research Articles - National Cancer Institute","contentType":"cgvCancerResearch","url":"https://www.cancer.gov/types/lymphoma/research/articles"},{"description":"Adult Hodgkin lymphoma treatment depends on the type (classical or nodular lymphocyte predominant) and includes chemotherapy and/or radiation therapy. Get detailed information about the prognosis and treatment of newly diagnosed and recurrent Hodgkin lymphoma in this expert-reviewed summary.","title":"Adult Hodgkin Lymphoma Treatment (PDQ®)\u2013Patient Version - National Cancer Institute","contentType":"pdqCancerInfoSummary","url":"https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq"},{"description":"AIDS-related lymphoma treatment may include chemotherapy, radiation therapy, high-dose chemotherapy with stem cell transplant, and/or targeted therapy. Get detailed information about newly diagnosed and recurrent AIDS-related lymphoma and treatment in this expert-reviewed summary.","title":"AIDS-Related Lymphoma Treatment (PDQ®)\u2013Patient Version - National Cancer Institute","contentType":"pdqCancerInfoSummary","url":"https://www.cancer.gov/types/lymphoma/patient/aids-related-treatment-pdq"},{"description":"Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, targeted therapy, and corticosteroids. Learn more about the treatment of newly diagnosed and recurrent primary CNS lymphoma cancer in this expert-reviewed summary.","title":"Primary CNS Lymphoma Treatment (PDQ®)\u2013Patient Version - National Cancer Institute","contentType":"pdqCancerInfoSummary","url":"https://www.cancer.gov/types/lymphoma/patient/primary-cns-lymphoma-treatment-pdq"},{"description":"Childhood Hodgkin lymphoma (classical or nodular lymphocyte-predominant HL) treatment usually involves chemotherapy and/or radiation therapy. Learn more about the symptoms, diagnosis, , staging, and treatment of in this expert-reviewed summary.","title":"Childhood Hodgkin Lymphoma Treatment (PDQ®)\u2013Patient Version - National Cancer Institute","contentType":"pdqCancerInfoSummary","url":"https://www.cancer.gov/types/lymphoma/patient/child-hodgkin-treatment-pdq"},{"description":"Copanlisib (Aliqopa®), a type of PI3K inhibitor, has been approved by the FDA for the treatment of patients with advanced follicular lymphoma.","title":"Copanlisib Approved for Follicular Lymphoma - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/news-events/cancer-currents-blog/2017/aliqopa-fda-follicular-lymphoma"},{"description":"This page lists cancer drugs approved by the Food and Drug Administration (FDA) for Hodgkin lymphoma. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries.","title":"Drugs Approved for Hodgkin Lymphoma - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/about-cancer/treatment/drugs/hodgkin-lymphoma"}]}